Skip to main content
OpenTrials

Clinical trial condition

Iron Overload

Explore clinical trials studying Iron Overload. Study availability and eligibility vary by location and protocol.

111 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Iron Overload trial results

Completed

Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis

NCT00395629

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Hemochromatosis, +7 more
Locations
  • UC Irvine/Long Beach Long Beach, California, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 18 locations
View Trial Details
Completed

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

NCT00171210

Conditions
Iron Metabolism Disorders, Iron Overload, Metabolic Diseases, +2 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital and Research Center at Oakland Oakland, California, United States
  • Stanford Hospital, Division of Oncology Stanford, California, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View all 49 locations
View Trial Details
Completed

Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients

NCT00110617

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +12 more
Locations
  • University of Alabama Pediatric Hematology/Oncology Birmingham, Alabama, United States
  • University of Alabama Medical center Birmingham, Alabama, United States
  • University of South Alabama Medical Center Mobile, Alabama, United States
  • University of South Alabama Mobile, Alabama, United States
View all 59 locations
View Trial Details
Completed

Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients

NCT00303329

Conditions
Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Children's Hospital and Research center at Oakland Oakland, California, United States
  • Stanford Hospital Stanford, California, United States
  • Childres's Hospital Boston Boston, Massachusetts, United States
  • New York Presbyterian Hospital New York, United States
View all 28 locations
View Trial Details

Related conditions